BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 33752897)

  • 1. Secondary myeloma in patients with chronic lymphoblastic leukemia: A case report and analysis of data from SEER database.
    Lin Z; Chen X; Huang Y; Zhao H; Li Z; Xu B
    Curr Probl Cancer; 2021 Oct; 45(5):100728. PubMed ID: 33752897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Racial differences in the presentation and outcomes of chronic lymphocytic leukemia and variants in the United States.
    Shenoy PJ; Malik N; Sinha R; Nooka A; Nastoupil LJ; Smith M; Flowers CR
    Clin Lymphoma Myeloma Leuk; 2011 Dec; 11(6):498-506. PubMed ID: 21889433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upper aerodigestive tract cancer in patients with chronic lymphocytic leukemia: incidence, stage, and outcome.
    Pagedar NA; Halfdanarson TR; Karnell LH; Hoffman HT; Funk GF
    Arch Otolaryngol Head Neck Surg; 2012 Dec; 138(12):1171-5. PubMed ID: 23247237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased incidence of malignant melanoma and other rare cutaneous cancers in the setting of chronic lymphocytic leukemia.
    Brewer JD; Shanafelt TD; Call TG; Cerhan JR; Roenigk RK; Weaver AL; Otley CC
    Int J Dermatol; 2015 Aug; 54(8):e287-93. PubMed ID: 25772131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes for lymphoid malignancies in the Nurses' Health Study (NHS) as compared to the Surveillance, Epidemiology and End Results (SEER) Program.
    Abel GA; Bertrand KA; Earle CC; Laden F
    Hematol Oncol; 2010 Sep; 28(3):133-6. PubMed ID: 19866451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gradual increase of chronic lymphocytic leukemia incidence in Korea, 1999-2010: comparison to plasma cell myeloma.
    Lee SJ; Tien HF; Park HJ; Kim JA; Lee DS
    Leuk Lymphoma; 2016; 57(3):585-9. PubMed ID: 26133722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in the risk of second primary malignancies among survivors of chronic lymphocytic leukemia.
    Kumar V; Ailawadhi S; Bojanini L; Mehta A; Biswas S; Sher T; Roy V; Vishnu P; Marin-Acevedo J; Alegria VR; Paulus A; Aulakh S; Iqbal M; Manochakian R; Tan W; Chanan-Khan A; Ailawadhi M
    Blood Cancer J; 2019 Sep; 9(10):75. PubMed ID: 31570695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A population level analysis of second hematological malignancies in chronic lymphocytic leukemia/small lymphocytic lymphoma survivors in the era of targeted therapies.
    Mishra R; Dima D; Kumar SA; Mian A; Taneja A; Karna R; Caimi PF; Hill BT; Dean R; Jagadeesh D
    Hematol Oncol; 2023 Dec; 41(5):884-893. PubMed ID: 37309225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and prognostic impact of other cancers in a population of long-term survivors of chronic lymphocytic leukemia.
    Falchi L; Vitale C; Keating MJ; Lerner S; Wang X; Elhor Gbito KY; Strom S; Wierda WG; Ferrajoli A
    Ann Oncol; 2016 Jun; 27(6):1100-1106. PubMed ID: 26912560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Racial differences in three major NHL subtypes: descriptive epidemiology.
    Li Y; Wang Y; Wang Z; Yi D; Ma S
    Cancer Epidemiol; 2015 Feb; 39(1):8-13. PubMed ID: 25560974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The risk of melanoma in patients with chronic lymphocytic leukemia; a population-based study.
    Turk T; Saad AM; Al-Husseini MJ; Gad MM
    Curr Probl Cancer; 2020 Apr; 44(2):100511. PubMed ID: 32115255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in leukemia incidence and survival in the United States (1973-1998).
    Xie Y; Davies SM; Xiang Y; Robison LL; Ross JA
    Cancer; 2003 May; 97(9):2229-35. PubMed ID: 12712476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of cutaneous T-cell lymphoma in patients with chronic lymphocytic leukemia and other subtypes of non-Hodgkin lymphoma.
    Chang TW; Weaver AL; Shanafelt TD; Habermann TM; Wriston CC; Cerhan JR; Call TG; Brewer JD
    Int J Dermatol; 2017 Nov; 56(11):1125-1129. PubMed ID: 28685851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival trends in chronic lymphocytic leukemia across treatment eras: US SEER database analysis (1985-2017).
    Alrawashdh N; Sweasy J; Erstad B; McBride A; Persky DO; Abraham I
    Ann Hematol; 2021 Oct; 100(10):2501-2512. PubMed ID: 34279676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma Cell Myeloma - 20-Year Comparative Survival and Mortality of Three Plasma Cell Myeloma ICD-O-3 Oncologic Phenotypes by Age, Sex, Race, Stage, Cohort Entry Time-Period and Disease Duration: A Systematic Review of 111,041 Cases for Diagnosis Years 1973-2014: (SEER*Stat 8.3.4).
    Milano AF
    J Insur Med; 2018; 47(4):203-211. PubMed ID: 30668210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating population-level outcomes in Chronic Lymphocytic leukemia in the era of novel therapies using the SEER registry.
    Muthiah C; Narra R; Atallah E; Juan W; Szabo A; Guru Murthy GS
    Leuk Res; 2024 May; 140():107496. PubMed ID: 38547577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of Richter's transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL): an analysis of the SEER database.
    Elnair R; Ellithi M; Kallam A; Shostrom V; Bociek RG
    Ann Hematol; 2021 Oct; 100(10):2513-2519. PubMed ID: 34279675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular mortality among patients with non-Hodgkin lymphoma: Differences according to lymphoma subtype.
    Abuamsha H; Kadri AN; Hernandez AV
    Hematol Oncol; 2019 Aug; 37(3):261-269. PubMed ID: 30916804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Additional B-cell malignancies in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL).
    Meacham PJ; Williams AM; Strawderman M; Baran AM; Archibald WJ; Wallace DS; Tschernia NP; Burack WR; Barr PM; Zent CS
    Leuk Lymphoma; 2020 Jul; 61(7):1636-1644. PubMed ID: 32175786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Other malignancies in chronic lymphocytic leukemia/small lymphocytic lymphoma.
    Tsimberidou AM; Wen S; McLaughlin P; O'Brien S; Wierda WG; Lerner S; Strom S; Freireich EJ; Medeiros LJ; Kantarjian HM; Keating MJ
    J Clin Oncol; 2009 Feb; 27(6):904-10. PubMed ID: 19114699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.